0R1F.LSE Bristol Myers Squibb Co.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
25.8x
P/B
-
ROE
-288.9%
Dividend yield
0.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2024.

Is 0R1F.LSE undervalued?

Graham number

The Graham number of Bristol Myers Squibb Co. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bristol Myers Squibb Co. fundamental analysis

No fundamental analysis for Bristol Myers Squibb Co. yet.

Bristol Myers Squibb Co. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bristol Myers Squibb Co.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresecta…

Full company profile